These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32598682)

  • 1. [Endothelial damage and circadian blood pressure profile in rheumatoid arthritis].
    Shilkina NP; Yunonin IE; Butusova SV; Mikhailova EV; Vinogradov AA
    Ter Arkh; 2019 May; 91(5):89-95. PubMed ID: 32598682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cerebral perfusion, arterial hypertension and endothelial dysfunction in rheumatoid arthritis].
    Shilkina NP; Spirin NN; Yunonin IE; Vinogradov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3. Vyp. 2):68-75. PubMed ID: 31184627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Markers of endothelial activation in rheumatoid arthritis].
    Shilikina NP; Yunonin IE; Vinogradov AA; Butusova SV
    Ter Arkh; 2012; 84(8):29-32. PubMed ID: 22994085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [System of microcirculation, markers of vascular wall damage and systematicity of the process in rheumatic diseases].
    Shilkina NP; Butusova SV; Driazhenkova IV
    Angiol Sosud Khir; 2014; 20(1):27-34. PubMed ID: 24722018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endothelial dysfunction in rheumatic patients].
    Shilkina NP; Butusova SV
    Klin Med (Mosk); 2013; 91(4):58-61. PubMed ID: 23879057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Markers of vascular endothelium activation in gout].
    Lapkina NA; Baranov AA; Barskova VG; Abaĭtova NE; Iakunina IA
    Ter Arkh; 2005; 77(5):62-5. PubMed ID: 15989007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease.
    de Groot L; Hinkema H; Westra J; Smit AJ; Kallenberg CG; Bijl M; Posthumus MD
    Arthritis Res Ther; 2011; 13(6):R205. PubMed ID: 22168993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
    de Groot L; Jager NA; Westra J; Smit AJ; Kallenberg CG; Posthumus MD; Bijl M
    Rheumatology (Oxford); 2015 Jul; 54(7):1257-61. PubMed ID: 25587178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
    Dessein PH; Joffe BI; Singh S
    Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis.
    Blann AD; Herrick A; Jayson MI
    Br J Rheumatol; 1995 Sep; 34(9):814-9. PubMed ID: 7582719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
    Foster W; Carruthers D; Lip GY; Blann AD
    J Rheumatol; 2010 Apr; 37(4):711-6. PubMed ID: 20156948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
    Lau CS; McLaren M; Hanslip J; Kerr M; Belch JJ
    Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of claudin-5 and von Willebrand factor in patients with rheumatoid arthritis.
    Gurol G; Ciftci IH; Harman H; Karakece E; Kamanli A; Tekeoglu I
    Int J Clin Exp Pathol; 2015; 8(2):1979-84. PubMed ID: 25973092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased arterial stiffness and indication of endothelial dysfunction in long-standing rheumatoid arthritis.
    Wållberg-Jonsson S; Caidahl K; Klintland N; Nyberg G; Rantapää-Dahlqvist S
    Scand J Rheumatol; 2008; 37(1):1-5. PubMed ID: 18189187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of severe, uncontrolled hypertension on endothelial activation: soluble vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1 and von Willebrand factor.
    Preston RA; Ledford M; Materson BJ; Baltodano NM; Memon A; Alonso A
    J Hypertens; 2002 May; 20(5):871-7. PubMed ID: 12011647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
    Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is small artery elasticity decreased prior to intima-media thickening in patients with longstanding rheumatoid arthritis?
    Hinkema HJ; Nienhuis HL; de Groot L; Smit AJ; van Roon AM; Bijl M; Posthumus MD
    J Rheumatol; 2011 Oct; 38(10):2133-40. PubMed ID: 21844153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial cells and rheumatoid arthritis: relationship with plasma markers of endothelial damage/dysfunction.
    Foster W; Shantsila E; Carruthers D; Lip GY; Blann AD
    Rheumatology (Oxford); 2009 Mar; 48(3):285-8. PubMed ID: 19153145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.
    Wållberg-Jonsson S; Cvetkovic JT; Sundqvist KG; Lefvert AK; Rantapää-Dahlqvist S
    J Rheumatol; 2002 May; 29(5):875-82. PubMed ID: 12022343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic venous thrombosis is related to systemic inflammatory response and to increased levels of circulating markers of endothelial dysfunction.
    Jezovnik MK; Poredos P
    Int Angiol; 2010 Jun; 29(3):226-31. PubMed ID: 20502419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.